Werner Kroll
Chief Tech/Sci/R&D Officer presso QUIDELORTHO CORPORATION
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Werner Kroll è vicepresidente senior di ricerca e sviluppo alla Quidel Corp. Il Dr. Kroll è anche nel consiglio dell'Associazione europea per la medicina personalizzata. Il Dr. Kroll è stato in precedenza VP & Head-Research & Innovation presso Novartis Institutes for Biomedical Research, Inc. Il Dr. Kroll ha ricevuto un dottorato dalla Philipps University di Marburg.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
QUIDELORTHO CORPORATION
0.05% | 28/03/2024 | 35 781 ( 0.05% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Werner Kroll
| Società | Posizione | Inizio |
|---|---|---|
| QUIDELORTHO CORPORATION | Chief Tech/Sci/R&D Officer | - |
| European Personalised Medicine Association | Director/Board Member | - |
Precedenti posizioni note di Werner Kroll
| Società | Posizione | Fine |
|---|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Werner Kroll
| Philipps University of Marburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| QUIDELORTHO CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| European Personalised Medicine Association |
- Borsa valori
- Insiders
- Werner Kroll
